Notal Vision
Yoav Lagstein has a strong background in engineering and product development. Yoav is currently serving as the Director of Product Engineering at Notal Vision since January 2022. Prior to this, Yoav worked at Orbotech for several years, holding various roles including Engineering Manager and Product Engineering Manager. In these positions, they were responsible for managing multidisciplinary teams, planning and executing new product launches, and ensuring smooth program lifecycles. Before Orbotech, Yoav was an Engineering Team Leader at Unitronics and a Mechanical Engineer at Madgal Glil-Yam, where they gained experience in mechanical development and product cycle management. Yoav began their career at IAI as a Mechanical Engineer, specializing in production engineering for commercial aircraft assembly. Overall, Yoav has accumulated extensive expertise in product engineering and development throughout their career.
Yoav Lagstein obtained a Bachelor of Science (BSc) degree in Mechanical Engineering from Tel Aviv University between 2003 and 2007.
This person is not in any offices
Notal Vision
Notal Vision is a patient-centric ophthalmic remote monitoring services provider extending retinal disease monitoring from the clinic to the home, providing physicians with remote monitoring services to support their patient care between office visits. With a proven approach to home-based, self-operated diagnostics, AI-enabled data analysis, and patient engagement, we help preserve patients’ vision. The Notal Vision Monitoring Center is a remote, Medicare credentialed ophthalmic provider and the epicenter of patient engagement. Led by practicing ophthalmologists and supported by certified ophthalmic professionals, the Monitoring Center offers a comprehensive nationwide age-related macular degeneration (AMD) home monitoring service for referred patients. The ForeseeHome® AMD Monitoring Program helps physicians detect the conversion to wet AMD early, leading to earlier treatment intervention and better visual outcomes. Our Home OCT pipeline technology will provide patient-initiated retinal OCT scans to support the management of patients with neovascular retinal diseases, complementing existing in-office imaging and standard of care treatments as well as emerging longer acting drugs and drug delivery systems.